EKF Diagnostics Holdings logo

EKF - EKF Diagnostics Holdings Share Price

81.58p -1.0  -1.2%

Last Trade - 2:15pm

Mid Cap
Market Cap £383.2m
Enterprise Value £364.2m
Revenue £77.5m
Position in Universe 666th / 1783
Unlock EKF Revenue
Relative Strength (%)
1m -2.05%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -4.84%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
30.0 38.6 41.6 42.5 44.9 65.3 77.2 82.0 +16.8%
+380.8 +186.9 -25.5 +195.3 +67.4 -3.56
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 June 2021, EkfDiagnostics Holding PLC revenues increased 46% to £38.6M.Net income increased from £4M to £9.1M. Revenues reflectGermany segment increase from £7.7M to £17.3M, Othersegment increase from £100K to £4.5M, USA segment increaseof 15% to £19.8M, United Kingdom segment increase from£242K to £4.6M, United States of America segment increaseof 9% to £16M, Germany segment increase of 44% to £4.3M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for EKF
Graphical History


EKF Revenue Unlock EKF Revenue

Net Income

EKF Net Income Unlock EKF Revenue

Normalised EPS

EKF Normalised EPS Unlock EKF Revenue

PE Ratio Range

EKF PE Ratio Range Unlock EKF Revenue

Dividend Yield Range

EKF Dividend Yield Range Unlock EKF Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
EKF EPS Forecasts Unlock EKF Revenue
Profile Summary

EKF Diagnostics Holdings plc is engaged in developing, manufacturing and supplying of products and services into the in-vitro diagnostic (IVD) market place. The Company manufactures and sells diagnostic instruments, reagents and certain ancillary products. The Company's point-of-care range includes hemoglobin analyzers, HbA1c analyzers and glucose analyzers for use in the screening, monitoring and diagnosis of patients, as well as rapid tests for pregnancy and common infectious diseases. The Company's Central Laboratory division includes a range of products for use in both large and small laboratory facilities. Its subsidiary, EKF Life Sciences, provides bulk diagnostic enzyme manufacturing and fermentation services. EKF Life Sciences specializes in producing enzymes, including Salicylate Hydroxylase and Beta-Hydroxybutyrate Dehydrogenase. Its products include Quo-Test A1c, Biosen C-Line and Biosen S-Line, STAT-Site M B-HB analyzer, sTNFR1 biomarker test kits and Altair 240.

Last Annual December 31st, 2020
Last Interim June 30th, 2021
Incorporated January 7, 2002
Public Since June 5, 2002
No. of Shareholders: n/a
No. of Employees: 356
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSE Aim All Share , FTSE Aim 100 ,
Exchange London Stock Exchange (AIM)
Shares in Issue 463,930,564
Free Float (0.0%)
Eligible for
EKF Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for EKF
Upcoming Events for EKF
Thursday 4th November, 2021
Dividend For EKF.L - 1.1000 GBX
Monday 28th March, 2022 Estimate
Full Year 2021 EKF Diagnostics Holdings PLC Earnings Release
Frequently Asked Questions for EKF Diagnostics Holdings
What is the EKF Diagnostics Holdings share price?

As of 2:15pm, shares in EKF Diagnostics Holdings are trading at 81.58p, giving the company a market capitalisation of £383.2m. This share price information is delayed by 15 minutes.

How has the EKF Diagnostics Holdings share price performed this year?

Shares in EKF Diagnostics Holdings are currently trading at 81.58p and the price has moved by 36.19% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the EKF Diagnostics Holdings price has moved by 3.55% over the past year.

What are the analyst and broker recommendations for EKF Diagnostics Holdings?

Of the analysts with advisory recommendations for EKF Diagnostics Holdings, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for EKF Diagnostics Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will EKF Diagnostics Holdings next release its financial results?

EKF Diagnostics Holdings is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-06-30
What is the EKF Diagnostics Holdings dividend yield?

The EKF Diagnostics Holdings dividend yield is 1.33% based on the trailing twelve month period.

Does EKF Diagnostics Holdings pay a dividend?

Last year, EKF Diagnostics Holdings paid a total dividend of 0.01, and it currently has a trailing dividend yield of 1.33%. Looking ahead, shares in EKF Diagnostics Holdings are due to go ex-dividend on 2021-11-04 and the next dividend pay date is 2021-12-01.

When does EKF Diagnostics Holdings next pay dividends?

EKF Diagnostics Holdings are due to go ex-dividend on 2021-11-04 and the next dividend pay date is 2021-12-01. The historic dividend yield on EKF Diagnostics Holdings shares is currently 1.33%.

How do I buy EKF Diagnostics Holdings shares?

To buy shares in EKF Diagnostics Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of EKF Diagnostics Holdings?

Shares in EKF Diagnostics Holdings are currently trading at 81.58p, giving the company a market capitalisation of £383.2m.

Where are EKF Diagnostics Holdings shares listed? Where are EKF Diagnostics Holdings shares listed?

Here are the trading details for EKF Diagnostics Holdings:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: EKF
What kind of share is EKF Diagnostics Holdings?

Based on an overall assessment of its quality, value and momentum, EKF Diagnostics Holdings is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a EKF Diagnostics Holdings share price forecast 2021?

Shares in EKF Diagnostics Holdings are currently priced at 81.58p. At that level they are trading at 16.83% discount to the analyst consensus target price of 98.09.

Analysts covering EKF Diagnostics Holdings currently have a consensus Earnings Per Share (EPS) forecast of 0.03709 for the next financial year.

How can I tell whether the EKF Diagnostics Holdings share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like EKF Diagnostics Holdings. Over the past six months, the relative strength of its shares against the market has been 6.43%. At the current price of 81.58p, shares in EKF Diagnostics Holdings are trading at 9.13% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the EKF Diagnostics Holdings PE Ratio?

The EKF Diagnostics Holdings PE ratio based on its reported earnings over the past 12 months is 24.81. The shares are currently trading at 81.58p.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of EKF Diagnostics Holdings?

EKF Diagnostics Holdings's management team is headed by:

Julian Baines - VCH
Richard Evans - FID
Christopher Mills - NEC
Carl Contadini - NID
Christian Rigg - NED
Who are the major shareholders of EKF Diagnostics Holdings?

Here are the top five shareholders of EKF Diagnostics Holdings based on the size of their shareholding:

Harwood Capital LLP Investment Advisor
Percentage owned: 28.21% (130.9m shares)
Canaccord Genuity Wealth Management Investment Advisor/Hedge Fund
Percentage owned: 6.46% (30.0m shares)
Liontrust UK Smaller Companies Fund Mutual Fund
Percentage owned: 6.29% (29.2m shares)
Marlborough UK Micro Cap Growth Retail Mutual Fund
Percentage owned: 5.7% (26.5m shares)
Liontrust Investment Partners LLP Investment Advisor
Percentage owned: 5.45% (25.3m shares)
Similar to EKF
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.